Autoimmune & Inflammation
In this section you will find Therapeutics Diseases & Conditions Autoimmune & Inflammation market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
4 Item(s)
per page
-
Global Multiple Sclerosis Drug Market 2010-2025
€1,739.00Published by Visiongain on Mar 3rd, 2010The multiple sclerosis (MS) treatments market is one of the largest for CNS disorders, with total pharmaceutical revenues of over $8bn in 2009. Revenues for MS treatments will rise significantly... Learn More -
Crohns Disease: A Therapy Update Report
€251.00Published by BioPharm Reports on Oct 1st, 2007Current, pipeline and emerging drugs for the treatment of Crohn’s Disease Learn More -
The Global Rheumatoid Arthritis Market Forecasts to 2012
€1,739.00Published by Visiongain on Mar 9th, 2007In a market believed to approach 5 million people in the leading pharma markets, the market for rheumatic anti-inflammatory drugs is both profitable and set to increase due to new launches. Learn More -
The World Asthma and COPD Treatment Market, 2006-2011: A Changing Market with Increasing Potential
€1,739.00Published by Visiongain on Aug 24th, 2006The asthma treatment market is a $15 billion market, driven by an increasing prevalence and yet without a treatment to cure this debilitating disease. Learn More
4 Item(s)
per page